日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial

新型减毒活疫苗(1型和3型口服脊髓灰质炎疫苗)在美国健康成人中的安全性和免疫原性:一项首次人体试验、观察者设盲、多中心、1期随机对照试验

Mercer, Laina D; Seña, Arlene C; Colgate, E Ross; Crothers, Jessica W; Wright, Peter F; Al-Ibrahim, Mohamed; Tritama, Erman; Vincent, Annelet; Mainou, Bernardo A; Zhang, Yiting; Konopka-Anstadt, Jennifer; Bandyopadhyay, Ananda S; Fix, Alan; Konz, John O; Gast, Chris

PSIV-12 An assessment of heavy metal exposure via urinalysis in dogs deployed to Maui wildfires

PSIV-12 通过尿液分析评估部署到毛伊岛山火中的犬只的重金属暴露情况

Juraska, Michal; Early, Angela M; Li, Li; Schaffner, Stephen F; Lievens, Marc; Khorgade, Akanksha; Simpkins, Brian; Hejazi, Nima S; Benkeser, David; Wang, Qi; Mercer, Laina D; Adjei, Samuel; Agbenyega, Tsiri; Anderson, Scott; Ansong, Daniel; Bii, Dennis K; Buabeng, Patrick B Y; English, Sean; Fitzgerald, Nicholas; Grimsby, Jonna; Kariuki, Simon K; Otieno, Kephas; Roman, François; Samuels, Aaron M; Westercamp, Nelli; Ockenhouse, Christian F; Ofori-Anyinam, Opokua; Lee, Cynthia K; MacInnis, Bronwyn L; Wirth, Dyann F; Gilbert, Peter B; Neafsey, Daniel E; Willer, David O; Wascotte, Valentine; Kim, Joon Hyung; Zahaf, Toufik; Talarico, Carla; Gorfinkel, Iris; Gervais, Pierre; Pharm, Pharm, L; Cunningham, Anthony L; Oostvogels, Lidia; Colindres, Romulo; Schuind, Anne; Mackey, Shea; Cooke, Reinaldo F; de Souza, Izadora; Mello, Ingo; Monteiro, Guilherme; Prado, Camila; Barreto, Yasmin; Gouvêa, Vinícius N; Perry, Erin B B; Baker, Janice; Santos, Flavia Dos; Oliveira, Poliana; Nichelson, Ashley; Graceli, Jones B

One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in Thailand

泰国NDV-HXP-S疫苗1/2期随机、安慰剂对照试验的一年随访

Phumratanaprapin, Weerapong; Luvira, Viravarn; Lawpoolsri, Saranath; Cowan, Juthaporn; Muangnoicharoen, Sant; Kamolratanakul, Supitcha; Sabmee, Yupa; Narakorn, Piengthong; Surichan, Somchaiya; Mercer, Laina D; Raghunandan, Rama; Polyak, Christina S; Wirachwong, Ponthip; Flores, Jorge; Innis, Bruce L; Pitisuttithum, Punnee

Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults

RTS,S/AS01E 的疗效仅在基线寄生虫血症而非基线无寄生虫血症的暴露于恶性疟原虫并接受药物治疗的肯尼亚成年人中观察到

Copeland, Nathanial K; Otieno, Lucas; Otieno, June Doryne; Otieno, Solomon; Chira, Salome; Ivinson, Karen; Onyango, Irene; Wasuna, Ruth; Akala, Hoseah; Onditi, Amos; Sifuna, Peter; Andagalu, Ben; Oyugi, Roselyne; Omondi, Mary; Amoit, Stellah; Locke, Emily; Gregory, Scott; Bergmann-Leitner, Elke S; Pindolia, Hema; Raine, Mike; Gast, Chris; Mercer, Laina D; Aponte, John J; Lievens, Marc; Ockenhouse, Christian F; Lee, Cynthia K

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial

表达SARS-CoV-2刺突蛋白的灭活重组新城疫病毒疫苗的安全性和免疫原性:一项随机、对照的II期试验

Thiem, Vu Dinh; Anh, Dang Duc; Ha, Vu Hai; Van Thom, Nguyen; Thang, Tran Cong; Mateus, Jose; Carreño, Juan Manuel; Raghunandan, Rama; Huong, Nguyen Mai; Mercer, Laina D; Flores, Jorge; Escarrega, E Alexandar; Raskin, Ariel; Thai, Duong Huu; Van Be, Le; Sette, Alessandro; Innis, Bruce L; Krammer, Florian; Weiskopf, Daniela

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial

在加纳和孟加拉国,一项随机、对照、开放标签、非劣效性3期临床试验评估了由大肠杆菌生产的二价人乳头瘤病毒疫苗(Cecolin)在9-14岁女孩中的免疫原性和安全性。

Agbenyega, Tsiri; Schuind, Anne E; Adjei, Samuel; Antony, Kalpana; Aponte, John J; Buabeng, Patrick B Y; Clemens, John D; Hossain, Lokman; Kemp, Troy J; Mercer, Laina D; Pinto, Ligia A; Qadri, Firdausi; Sukraw, Kristen; Bhat, Niranjan; Zaman, Khalequ

Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection

鉴定RTS,S/AS01疫苗诱导的体液生物标志物,以预测对受控人类疟疾感染的保护作用

Spreng, Rachel L; Seaton, Kelly E; Lin, Lin; Hilliard, Sir'Tauria; Horn, Gillian Q; Abraha, Milite; Deal, Aaron W; Li, Kan; Carnacchi, Alexander J; Feeney, Elizabeth; Shabbir, Siam; Zhang, Lu; Bekker, Valerie; Mudrak, Sarah V; Dutta, Sheetij; Mercer, Laina D; Gregory, Scott; King, C Richter; Wille-Reece, Ulrike; Jongert, Erik; Kisalu, Neville K; Tomaras, Georgia D; Dennison, S Moses

Socioeconomic, Demographic, and Environmental Factors May Inform Malaria Intervention Prioritization in Urban Nigeria

社会经济、人口和环境因素可能影响尼日利亚城市地区疟疾干预措施的优先次序。

Chiziba, Chilochibi; Mercer, Laina D; Diallo, Ousmane; Bertozzi-Villa, Amelia; Weiss, Daniel J; Gerardin, Jaline; Ozodiegwu, Ifeoma D

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study

灭活脊髓灰质炎病毒疫苗在健康成人中含或不含大肠杆菌双突变耐热毒素 (dmLT) 佐剂的安全性、耐受性和免疫原性;一项 1 期随机研究

Rahsan Erdem, Ilse De Coster, Kanchanamala Withanage, Laina D Mercer, Arnaud Marchant, Martin Taton, Nathalie Cools, Eva Lion, Fred Cassels, Deborah Higgins, Karen Ivinson, Emily Locke, Kutub Mahmood, Peter F Wright, Chris Gast, Jessica A White, Margaret E Ackerman, Jennifer L Konopka-Anstadt, Berna

Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition

在被占领的巴勒斯坦领土引入 ROTAVAC®:对腹泻发病率、轮状病毒流行率和基因型组成的影响

Rennert, Wolfgang; Hindiyeh, Musa; Allahham, Majd; Mercer, Laina D; Hamad, Khalil I; Ghuneim, Nedal I; A M Eljaro, Zuheir; Abu-Awwad, Fakhr; Bozya, Yaser; Hjaija, Diaa; Bhat, Niranjan; Leader, Troy; Ramlawi, Asad; Marzouqa, Hiyam